(Q28318472)

English

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer

scientific article (publication date: April 1979)

In more languages

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer (English)

0 references

metastatic breast cancer

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

author name string

F. Pannuti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

A. Martoni

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

A. R. Di Marco

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

E. Piana

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

F. Saccani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

G. Becchi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

G. Mattioli

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

F. Barbanti

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

G. A. Marra

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

W. Persiani

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

L. Cacciari

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

F. Spagnolo

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

D. Palenzona

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

G. Rocchetta

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86447

13 November 2022

language of work or name

0 references

publication date

April 1979

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:0014296479900975?httpAccept=text/xml

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

https://api.elsevier.com/content/article/PII:0014296479900975?httpAccept=text/plain

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

European Journal of Cancer

0 references

15

0 references

593-601

0 references

4

0 references

Hormonal therapy in cancer of the breast. III. Effect of progesterone on clinical course and hormonal excretion

1

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Progestin therapy of breast cancer: comparison of agents

5

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Hormonal therapy in cancer of the breast. XXIV. Effect of corticosterone or medroxyprogesterone acetate on clinical course and hormonal excretion

6

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Treatment of breast cancer with medroxyprogesterone acetate

7

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group

8

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Clinical trial of delalutin in the treatment of advanced mammary carcinoma in postmenopausal women

10

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Progestagens and advanced breast cancer.

11

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Hormonal therapy of metastatic female breast carcinoma. I. 9 alpha-Bromo-11-ketoprogesterone

12

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Clinical and pharmacological observations of the effects of 9-alpha-bromo-11-beta-ketoprogesterone in patients with carcinoma of the breast

13

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

A comparative study of 9alpha-bromo-11beta-keto-progesterone and prednisolone in the treatment of advanced carcinoma of the female breast

14

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Norethisterone acetate (SH420) in advanced breast cancer

22

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Norethisterone acetate in the treatment of advanced breast cancer

23

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Hormonal therapy in cancer of the breast. XIV. The effect of 19-nortestosterone propionate therapy on clinical course and hormonal excretion

24

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

HORMONAL THERAPY IN CANCER OF THE BREAST. 23. EFFECT OF 7-ALPHA-METHYL-19-NORTESTOSTERONE ACETATE AND TESTOSTERONE PROPIONATE ON CLINICAL COURSE AND HORMONAL EXCRETION

27

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

A dose-response evaluation of androgens in the treatment of metastatic breast cancer

30

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Effect of methenolone enanthate (NSC-64967) in advanced cancer of the breast

31

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Disseminated breast cancer: Evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination

33

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

A clinical trial of megestrol acetate in advanced breast cancer

34

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Further clinical studies with megestrol acetate in advanced breast cancer

35

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

39

1 reference

10.1016/0014-2964(79)90097-5

https://api.crossref.org/works/10.1016/0014-2964(79)90097-5

13 November 2022

Identifiers

10.1016/0014-2964(79)90097-5

0 references

release_edch7mb3uje5xbk7bqur63c27u

1 reference

https://api.fatcat.wiki/v0/release/edch7mb3uje5xbk7bqur63c27u

24 November 2022

based on heuristic

mapped directly with Wikidata item

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28318472&oldid=1837010690"